Siemens Healthineers AG (SEMHF) Stock Forecast & Price Target

Compare

186 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

SEMHF Analyst Ratings

Moderate Buy

8 Buy

4 Hold

0 Sell

Based on 12 analysts giving stock ratings to

Siemens

Healthineers AG

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

SEMHF Stock 12 Month Forecast

Average Price Target

$63.01

▲(12.06% Upside)

Based on 12 Wall Street analysts offering 12 month price targets for Siemens Healthineers AG in the last 3 months. The average price target is $63.01 with a high forecast of $71.15 and a low forecast of $52.23. The average price target represents a 12.06% change from the last price of $56.23.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"48":"$48","54":"$54","60":"$60","66":"$66","72":"$72"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":71.1475385,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$71.15</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":63.012472181818175,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$63.01</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":52.229025,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$52.23</span>\n  </div></div>","useHTML":true}}],"tickPositions":[48,54,60,66,72],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2025","6":"Jul<br/>2025","9":"Oct<br/>2025","12":"Jan<br/>2026","25":"Jan<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,52.96,54.359041423076924,55.75808284615385,57.15712426923077,58.556165692307694,59.95520711538462,61.35424853846153,62.75328996153846,64.15233138461538,65.5513728076923,66.95041423076923,68.34945565384615,69.74849707692307,{"y":71.1475385,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,52.96,53.73326709090909,54.50653418181818,55.27980127272727,56.05306836363636,56.82633545454545,57.599602545454545,58.37286963636363,59.146136727272726,59.91940381818181,60.69267090909091,61.465937999999994,62.23920509090908,{"y":63.012472181818175,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,52.96,52.90377115384616,52.84754230769231,52.791313461538465,52.735084615384615,52.67885576923077,52.62262692307692,52.56639807692308,52.51016923076923,52.453940384615386,52.397711538461536,52.34148269230769,52.28525384615384,{"y":52.229025,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":52.33,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":56.2,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":54.68,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":53,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":53.42,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":52.05,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":56.23,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":53.85,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":55.25,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 42,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":56.05,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 39,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":54.45,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 48,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":49.52,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":52.96,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$71.15

Average Price Target$63.01

Lowest Price Target$52.23

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Natalia Webster

RBC Capital

$55

Buy

-2.19%

Downside

Reiterated

01/15/26

Analysts' Top Healthcare Picks: Diaceutics (DIUXF), Siemens Healthineers AG (SEMHF)

Graham Doyle

UBS

$58.03→$59.19

Hold

5.27%

Upside

Reiterated

01/15/26

UBS Keeps Their Hold Rating on Siemens Healthineers AG (SEMHF)

David Adlington

J.P. Morgan

$71.15

Buy

26.53%

Upside

Reiterated

01/15/26

Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (Other OTC: SEMHF) and Insmed (NASDAQ: INSM)

Susannah Ludwig

Bernstein

$61.4

Buy

9.19%

Upside

Reiterated

01/13/26

Bernstein Remains a Buy on Siemens Healthineers AG (SEMHF)

Falko Friedrichs

Deutsche Bank

$53.39

Hold

-5.05%

Downside

Reiterated

01/06/26

Analysts Offer Insights on Healthcare Companies: Bioxcel Therapeutics (NASDAQ: BTAI), Sanofi (Other OTC: SNYNF) and Siemens Healthineers AG (Other OTC: SEMHF)

Julien Dormois

Jefferies

$69.64

Buy

23.84%

Upside

Reiterated

12/19/25

Siemens Healthineers AG (SEMHF) Receives a Buy from Jefferies

Hassan Al-Wakeel

Barclays

$71.38→$70.8

Buy

25.91%

Upside

Reiterated

12/18/25

Analysts Offer Insights on Healthcare Companies: Novan (NASDAQ: NOVN) and Siemens Healthineers AG (Other OTC: SEMHF)

Aisyah Noor

Morgan Stanley

$55.71→$52.23

Hold

-7.12%

Downside

Reiterated

12/15/25

Siemens Healthineers price target lowered to EUR 45 from EUR 48 at Morgan StanleySiemens Healthineers price target lowered to EUR 45 from EUR 48 at Morgan Stanley

Unknown Analyst

Exane BNP Paribas

Not Ranked

Exane BNP Paribas

$55.71

Hold

-0.92%

Downside

Downgraded

12/10/25

Siemens Healthineers AG (SEMHF) was downgraded to a Hold Rating at Exane BNP Paribas

Veronika Dubajova

Citi

$71.96→$67.32

Buy

19.72%

Upside

Reiterated

11/17/25

Siemens Healthineers price target lowered to EUR 58 from EUR 62 at CitiSiemens Healthineers price target lowered to EUR 58 from EUR 62 at Citi

Oliver Reinberg

Kepler Capital

$68.48

Buy

21.78%

Upside

Reiterated

11/13/25

Kepler Capital Remains a Buy on Siemens Healthineers AG (SEMHF)

Unknown Analyst

DZ BANK AG

Not Ranked

DZ BANK AG

Buy

―

Reiterated

11/07/25

DZ BANK AG Sticks to Its Buy Rating for Siemens Healthineers AG (SEMHF)

Sam England

Berenberg Bank

$66.16

Buy

17.65%

Upside

Reiterated

09/26/25

Siemens Healthineers AG (SEMHF) Receives a Buy from Berenberg Bank

Julien Ouaddour

Bank of America Securities

$76.6→$75.44

Buy

34.16%

Upside

Reiterated

07/31/25

Bank of America Securities Reaffirms Their Buy Rating on Siemens Healthineers AG (SEMHF)

Nico Chen

DBS

$62.67→$68.48

Buy

21.78%

Upside

Reiterated

05/15/25

Buy Rating for Siemens Healthineers AG: Strong Revenue Growth and Technological Leadership Drive Positive Outlook

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Natalia Webster

RBC Capital

$55

Buy

-2.19%

Downside

Reiterated

01/15/26

Analysts' Top Healthcare Picks: Diaceutics (DIUXF), Siemens Healthineers AG (SEMHF)

Graham Doyle

UBS

$58.03→$59.19

Hold

5.27%

Upside

Reiterated

01/15/26

UBS Keeps Their Hold Rating on Siemens Healthineers AG (SEMHF)

David Adlington

J.P. Morgan

$71.15

Buy

26.53%

Upside

Reiterated

01/15/26

Analysts Offer Insights on Healthcare Companies: Siemens Healthineers AG (Other OTC: SEMHF) and Insmed (NASDAQ: INSM)

Susannah Ludwig

Bernstein

$61.4

Buy

9.19%

Upside

Reiterated

01/13/26

Bernstein Remains a Buy on Siemens Healthineers AG (SEMHF)

Falko Friedrichs

Deutsche Bank

$53.39

Hold

-5.05%

Downside

Reiterated

01/06/26

Analysts Offer Insights on Healthcare Companies: Bioxcel Therapeutics (NASDAQ: BTAI), Sanofi (Other OTC: SNYNF) and Siemens Healthineers AG (Other OTC: SEMHF)

Julien Dormois

Jefferies

$69.64

Buy

23.84%

Upside

Reiterated

12/19/25

Siemens Healthineers AG (SEMHF) Receives a Buy from Jefferies

Hassan Al-Wakeel

Barclays

$71.38→$70.8

Buy

25.91%

Upside

Reiterated

12/18/25

Analysts Offer Insights on Healthcare Companies: Novan (NASDAQ: NOVN) and Siemens Healthineers AG (Other OTC: SEMHF)

Aisyah Noor

Morgan Stanley

$55.71→$52.23

Hold

-7.12%

Downside

Reiterated

12/15/25

Siemens Healthineers price target lowered to EUR 45 from EUR 48 at Morgan StanleySiemens Healthineers price target lowered to EUR 45 from EUR 48 at Morgan Stanley

Unknown Analyst

Exane BNP Paribas

Not Ranked

Exane BNP Paribas

$55.71

Hold

-0.92%

Downside

Downgraded

12/10/25

Siemens Healthineers AG (SEMHF) was downgraded to a Hold Rating at Exane BNP Paribas

Veronika Dubajova

Citi

$71.96→$67.32

Buy

19.72%

Upside

Reiterated

11/17/25

Siemens Healthineers price target lowered to EUR 58 from EUR 62 at CitiSiemens Healthineers price target lowered to EUR 58 from EUR 62 at Citi

Oliver Reinberg

Kepler Capital

$68.48

Buy

21.78%

Upside

Reiterated

11/13/25

Kepler Capital Remains a Buy on Siemens Healthineers AG (SEMHF)

Unknown Analyst

DZ BANK AG

Not Ranked

DZ BANK AG

Buy

―

Reiterated

11/07/25

DZ BANK AG Sticks to Its Buy Rating for Siemens Healthineers AG (SEMHF)

Sam England

Berenberg Bank

$66.16

Buy

17.65%

Upside

Reiterated

09/26/25

Siemens Healthineers AG (SEMHF) Receives a Buy from Berenberg Bank

Julien Ouaddour

Bank of America Securities

$76.6→$75.44

Buy

34.16%

Upside

Reiterated

07/31/25

Bank of America Securities Reaffirms Their Buy Rating on Siemens Healthineers AG (SEMHF)

Nico Chen

DBS

$62.67→$68.48

Buy

21.78%

Upside

Reiterated

05/15/25

Buy Rating for Siemens Healthineers AG: Strong Revenue Growth and Technological Leadership Drive Positive Outlook

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Siemens Healthineers AG

3 Months

xxx

Success Rate

7/13 ratings generated profit

Average Return

+1.51%

reiterated a xxx

rating 9 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 53.85% of your transactions generating a profit, with an average return of +1.51% per trade.

1 Year

Hassan Al-WakeelBarclays

Success Rate

17/31 ratings generated profit

Average Return

+2.53%

reiterated a buy rating last month

Copying Hassan Al-Wakeel's trades and holding each position for 1 Year would result in 54.84% of your transactions generating a profit, with an average return of +2.53% per trade.

2 Years

xxx

Success Rate

16/22 ratings generated profit

Average Return

+2.62%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 72.73% of your transactions generating a profit, with an average return of +2.62% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

SEMHF Analyst Recommendation Trends

Rating

Sep 25

Oct 25

Nov 25

Dec 25

Jan 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, SEMHF has received 22 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings. SEMHF average Analyst price target in the past 3 months is 63.01.

Each month's total comprises the sum of three months' worth of ratings.

SEMHF Financial Forecast

SEMHF Earnings Forecast

Next quarter’s earnings estimate for SEMHF is $0.52 with a range of $0.49 to $0.56. The previous quarter’s EPS was $0.79. SEMHF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year SEMHF has Performed in-line its overall industry.

SEMHF Sales Forecast

Next quarter’s sales forecast for SEMHF is $6.10B with a range of $5.54B to $6.34B. The previous quarter’s sales results were $7.36B. SEMHF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year SEMHF has Performed in-line its overall industry.

SEMHF Stock Forecast FAQ

What is SEMHF’s average 12-month price target, according to analysts?

Based on analyst ratings, Siemens Healthineers AG’s 12-month average price target is 63.01.

What is SEMHF’s upside potential, based on the analysts’ average price target?

Siemens Healthineers AG has 12.06% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is SEMHF a Buy, Sell or Hold?

Siemens Healthineers AG has a consensus rating of Moderate Buy which is based on 8 buy ratings, 4 hold ratings and 0 sell ratings.

What is Siemens Healthineers AG’s price target?

The average price target for Siemens Healthineers AG is 63.01. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $71.15 ,the lowest forecast is $52.23. The average price target represents 12.06% Increase from the current price of $56.23.

What do analysts say about Siemens Healthineers AG?

Siemens Healthineers AG’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.

How can I buy shares of SEMHF?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Siemens Healthineers AG (SEMHF) Stock Forecast & Price Target

SEMHF Analyst Ratings

SEMHF Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Siemens Healthineers AG

SEMHF Analyst Recommendation Trends

SEMHF Financial Forecast

SEMHF Earnings Forecast

SEMHF Sales Forecast

SEMHF Stock Forecast FAQ

Detailed List of Analyst Forecasts